Patty Eisenhaur
Investor Relations Kontakt bei MOMENTA PHARMACEUTICALS, INC.
Aktive Positionen von Patty Eisenhaur
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Investor Relations Kontakt | - | - |
| EVC Group, Inc. | Corporate Officer/Principal | - | - |
Karriereverlauf von Patty Eisenhaur
Ehemalige bekannte Positionen von Patty Eisenhaur
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALBANY MOLECULAR RESEARCH, INC. | Investor Relations Kontakt | 01.08.2014 | 01.06.2018 |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Investor Relations Contact | 2 |
| Corporate Officer/Principal | 1 |
Sektoral
| Commercial Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
| EVC Group, Inc. | |
Curia Global, Inc.
 Curia Global, Inc. Miscellaneous Commercial ServicesCommercial Services Curia Global, Inc. engages in drug research and development, and manufacturing. It offers drug delivery, drug development, analytical services, API development and manufacturing, and drug product solutions. The company was founded by Thomas E. D'Ambra on June 19, 1991 and is headquartered in Albany, NY. | Commercial Services |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Patty Eisenhaur
- Erfahrung